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1imiting Factors of Exercise Performance 1 Year After
ung Transplantation
. D. Reinsma, MSc,a N. H. T. ten Hacken, MD, PhD,b R. G. Grevink, MD,b W. van der Bij, MD, PhD,b
. H. Koëter, MD, PhD,b and E. van Weert, MSca
ackground: After lung transplantation (LTx) exercise capacity frequently remains limited, despite significantly
improved pulmonary function. The aim of this study was to evaluate maximal exercise capacity and
peripheral muscle force before and 1 year after LTx, and to determine whether peripheral muscle
force and lactate threshold (LT) limit exercise capacity 1 year after LTx.
ethods: Twenty-five subjects (mean age 43 years, 8 women and 17 men, 4 single-lung transplantations) were
included in the study. Measurements included maximal exercise capacity, lactate threshold
(symptom-limited bicycle ergometer test) and muscle force test (hand-held dynamometer) were
performed before and 1 year after LTx.
esults: Before LTx, all patients showed severe exercise intolerance (mean  SD): work capacity (Wpeak),
11.6  18 W; peak oxygen uptake (VO2), 8.6  3.6 ml/min/kg. After LTx, exercise capacity
improved significantly: Wpeak, 69  27 W (p  0.001); peak VO2, 15.7  4.3 ml/min/kg (p 
0.001). Ventilatory factors did not appear to limit exercise capacity. Quadriceps muscle force
pre- vs post-LTx was: 248  73 N vs 281  68 N (p  0.05). Post-LTx, a significant correlation
was found between LT and exercise capacity (r  0.76, p  0.001), between muscle force and
exercise capacity (r  0.41, p  0.05) and between the LT and muscle force (r  0.53, p 
0.01).
onclusions: The occurrence of an early and pathologic LT and peripheral muscle weakness contributes to the
limitation of exercise capacity and reflects a peripheral deficit post-LTx. J Heart Lung Transplant
























lung transplantation (LTx) has become an established
ode of treatment for many forms of end-stage pulmo-
ary disease. Upon recovery post-operatively, double-
ung transplant (DLT) recipients typically have near-
ormal spirometry with mildly impaired diffusion
apacity.1 After single-lung transplantation (SLT), spi-
ometry typically remains partially abnormal, reflecting
he pathology of the remaining native lung.1
Despite significantly improved pulmonary function,
ost transplant recipients have an exercise impairment
s defined by lower-than-normal values of peak oxygen
ptake (peak VO2) and maximum achievable work rate
Wpeak). VO2 peak ranges from 40% to 60% of predicted
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310alues, regardless of the transplantation type (single or
ouble LTx) or underlying pulmonary disease.2–4 The
educed peak VO2 is accompanied by low peak cardiac
requency, low oxygen pulse at peak exercise, high
espiratory exchange ratio and early lactic acidosis,
onsistent with a defect originating in the peripheral
uscles.3
Several studies have confirmed that muscle function
hanges after LTx. Pantoja et al demonstrated reduced
eripheral muscle strength of the ankle dorsiflexor
uscle groups between 11 and 102 months after LTx.5
educed total leg strength and work capacity were
oted in another group of patients, most of whom were
18 months post-LTx.6 Reduced oxygen utilization by
he vastus lateralis muscle was demonstrated after LTx
y 31-phosphorus (31P)-magnetic resonance spectros-
opy and by optical near-infrared spectroscopy.7,8 Skel-
tal muscle biopsies from the quadriceps exhibited
ower activity of the oxidative enzymes, lower propor-
ion of type 1 (fatigue-resistant) fibers, higher lactate
oncentration, low intramyocyte pH, and reduced aden-
sine triphosphate (ATP) content.9 Together, these
tudies support the hypothesis that the limited exercise
apacity found after LTx may be due, at least in part, to
imited muscle strength and limited endurance capacity
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Volume 25, Number 11The question arises as to when exactly peripheral
uscle performance deteriorates. After LTx, factors
uch as immobilization, poor nutritional status, cata-
olic conditions and pharmacologic treatment with
orticosteroids or calcineurin inhibitors may contribute
o peripheral muscle wasting or dysfunction. However,
lready before LTx the underlying pulmonary disease
ay result in peripheral muscle deconditioning and
trophy. Indeed, in the pre-transplant condition of
hronic obstructive pulmonary disease (COPD) a
arked reduction in type 1 fiber proportion, reduced
uscle mass, and decreased concentrations of oxida-
ive enzymes in the quadriceps femoris have been
eported.10
Until now, there has been, to our knowledge, little
nformation available regarding exercise performance
nd peripheral muscle function before and after lung
ransplantation, at well-defined time-points. Therefore,
he primary aim of the present study was to evaluate in
longitudinal manner the limitations of maximal exer-
ise capacity together with peripheral muscle force
efore and 1 year after LTx. We hypothesized that








mphysema SLT F 41
mphysema SLT F 50
mphysema DLT F 37
mphysema DLT F 45
mphysema DLT F 45
mphysema DLT F 50
mphysema DLT F 51
mphysema DLT F 54
mphysema DLT F 56
mphysema DLT M 44
mphysema DLT M 52
ystic fibrosis DLT F 29
ystic fibrosis DLT F 38
ystic fibrosis DLT F 38
ystic fibrosis DLT M 17
ystic fibrosis DLT M 35
ulmonary fibrosis SLT F 39
ulmonary fibrosis SLT M 42
ulmonary fibrosis DLT M 41
ulmonary fibrosis DLT M 53
ulmonary fibrosis DLT M 55
ronchiectasis DLT F 48
ronchiectasis DLT F 56
AM DLT F 34
isenmenger syndrome DLT F 21
ean 4 SLT 8 F 43
D 21 DLT 17 M (10)
LT, single-lung transplant; DLT, double-lung transplant; BMI, body mass index




he patients studied were a cohort of single- and
ouble-lung transplantation (SLT and DLT, respectively)
ecipients at the University Medical Center Groningen
UMCG, The Netherlands). Twenty-five patients (4 SLTs,
1 DLTs) who survived 1 year after transplantation
ere studied both before (mean SD: 620 477 days)
nd 1 year after transplantation. All patients had end-
tage respiratory disease: emphysema (n  11); idio-
athic pulmonary fibrosis (n  5); cystic fibrosis (n  5);
ronchiectasis (n 2); Eisenmenger’s syndrome (n 1);
nd lymphangio-leiomyomatosis (n  1). None of the
ecipients had undergone re-transplantations. Baseline
atient characteristics are shown in Table 1. After
ischarge, all patients were instructed to exercise
walking, cycling, etc.) regularly, without a prescribed
tructured exercise program, supervised by a physio-











4 27.0 128.0 85.7 0
1 21.0 111.8 50.2 0
3 21.5 130.6 58.7 10
9 28.6 94.3 69.6 30
3 29.1 120.3 120.9 0
7 27.3 83.2 49.4 0
3 27.3 104.0 54.8 10
3 26.7 111.5 68.5 0
1 55.8 61.0 39.2 0
9 17.7 ND 72.6 0
1 30.0 117.0 63.0 0
9 59.2 62.8 62.7 40
3 44.8 60.9 35.0 0
0 55.8 52.2 59.4 30
2 52.0 69.7 35.7 30
2 34.1 104.0 57.7 0
2 81.5 26.6 86.3 0
4 60.8 48.0 58.4 60
1 81.0 43.8 40.6 50
7 82.0 47.0 69.4 20
1 73.5 63.4 69.8 0
3 32.0 74.2 57.3 0
2 82.6 38.0 80.1 0
6 25.5 116.0 57.2 0
7 85.1 60.0 62.7 10
6 46.5 80.3 62.0 11.6
6) (23.4) (31.7) (18.6) (18.0)
V1/FVC, forced volume in 1 second as percentage of forced vital capacity; TLC,
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November 2006acrolimus (FK) (48% CyA and 52% FK), azathioprine or
ycophenolate (87.5% and 12.5%) and prednisone
100%). Hemoglobin concentration was measured in
ll transplant recipients (mean  SD: men, 7.45 
.96 mmol/liter; women, 6.69  0.74 mmol/liter).
pproval for the use of clinical data in this study was
btained from our institutional review board on
uman research. Written informed consent was ob-
ained from all patients.
ulmonary Function
low volume measurements included forced expiration
olume in 1 second (FEV1) and inspiratory vital capacity
IVC). Total lung capacity (TLC) and functional residual
apacity (FRC) were measured by body plethysmogra-
hy (Jaeger, Wurzburg, Germany). Values were ex-
ressed as a percentage of reference values.11 All
easurements were performed according to European
espiratory Society (ERS) standards.12
eripheral Muscle Force
aximal voluntary isometric muscle force of the mus-
uli quadriceps, biceps brachii and triceps brachii were
easured bilaterally using a hand-held dynamometer
MicroFET II, Hoggan Health Industries, Draper, UT).
ll actions were tested in gravity-neutralized positions,
ith the exception of knee extension. During the
uadriceps force measurement, the patients were sit-
ing on a table and the dynamometer was positioned at
he ventral side of the leg just proximal to the ankle.
he force of the biceps brachii and triceps brachii was
easured while the patient was in a supine position.
he upper arm rested horizontally with the elbow in
0° flexion. For the biceps brachii measurement the
ynamometer was placed on the ventral side of the arm
ust proximal to the wrist joint. The triceps brachii was
easured with the dynamometer placed on the dorsal
ide of the arm just proximal to the wrist joint. During
ll measurements the break method was used. In utiliz-
ng this method, the examiner gradually overcomes the
orce produced by the patient until the extremity gives
way.13 All measurements were performed three times.
ean muscle force values of the dominant side were
alculated and used for analyses. Predicted values were
alculated using the equations of Bohannon.14
ardiopulmonary Exercise Testing
aximal exercise capacity was measured using an
ncremental symptom-limited bicycle ergometer test.
eart rate and rhythm were monitored by electrocardi-
graphy. A brachial or radial artery catheter was in-
erted for periodic sampling of blood for analysis of pH,
aO2, PaCO2 and lactate. Samples were drawn at rest and
very 3 minutes during exercise, in the last 45 seconds
f each increment. Patients respired through a mouth- Piece and wore a nose-clip. Minute ventilation (VE),
xygen uptake (VO2) and carbon dioxide output (VCO2)
ere measured and calculated from a mixing chamber
very 30 seconds (MMC Oxygen Champion, Jeager,
urzburg). Calibration of gas analyzers and flow trans-
ucers was performed before each test. The test re-
uired 3 minutes of seated rest on the ergometer for
ollecting baseline measurements. Subjects were then
nstructed to begin pedaling at 60 to 70 revolutions per
inute. After 3 minutes of unloaded cycling, power
as increased every 3 minutes by 15 W. The patients
ere encouraged to cycle as long as possible. Peak
alues for all variables were obtained by averaging data
ver the last 20 seconds of maximum completed work.
eak VO2 was predicted using formulas for healthy
ubjects.15 Peak VE was predicted by the formula of
arter (37.5 * FEV1).
16 The lactate threshold (LT) was
etermined by plotting the log lactate concentration
gainst the log VO2 and taking the break-point of the
lope. The LT was expressed as percentage of predicted
eak VO2.
17
To determine the limiting factor during exercise
he following definitions were used: cardiocircula-
ory limitation was defined as having no heart rate
eserve (peak heart rate at or above predicted peak
eart rate); ventilatory limitation was defined as
aving a breathing reserve of 11 liters/min and/or a
CO2 becoming 6 kPa
15; oxygen uptake limitation
as defined as an increase in alveolar–arterial oxygen
ension of 2 kPa during exercise18; and peripheral
uscle limitation was defined as having none of the
ther limitations in combination with a low lactate
hreshold (40% of predicted VO2).
15
tatistics
tatistical analysis was performed using SPSS/PC11
oftware. Shapiro–Wilk tests were used to determine
hether variables of interest were normally distributed.
ifferences pre- and post-LTx were analyzed using the
tudent’s t-test for paired samples (for normally distrib-
ted variables) and Wilcoxon tests (in case of skewed
istribution). p  0.05 was considered statistically
ignificant. Correlations between variables were inves-
igated using the 2-tailed Pearson’s correlation coeffi-
ient (for normally distributed variables) and Spear-
an’s correlation coefficient (in case of skewed
istribution).
ESULTS
ulmonary Function Before and 1 Year After LTx
fter LTx dynamic lung volumes (FEV1, FVC) improved
ignificantly in all transplant recipients, in contrast to
tatic lung volumes (TLC) (Table 2). Also, PaO2 and
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Volume 25, Number 11xercise Capacity Before and 1 Year After LTx
efore LTx, peak VO2 and Wpeak were below normal
alues in all recipients (Table 3). The limitations in
xercise, as defined in the Methods section, were
aused by impaired ventilation in 21 patients and by
mpaired oxygen uptake in 4 patients. Before LTx, the
actate threshold could not be determined in 15 patients
ecause of peak workloads of 0 W. In the remaining 10
ubjects, lactate threshold was 22.4  9.7% (mean  SD)
f the predicted peak VO2.
After LTx, all recipients showed significant improve-
ents in peak VO2 and Wpeak (Table 3). Peak VE and VO2
mproved approximately 2-fold, and peak workload
-fold. Nevertheless, mean VO2max and Wpeak remained
ignificantly below normal values. Limited exercise
apacity was not due to high heart rate, impaired
entilation or low oxygen uptake. The average lactate
hreshold was 30.0  11.3% of predicted peak VO2.
hus, in all subjects the criteria for peripheral muscle
imitation were met. However, 8 patients also showed
n increase in alveolar–arterial oxygen tension of 2 kPa
t maximal exercise, indicating an oxygen uptake limi-
ation in combination with a peripheral limitation.
here were no significant differences between patients
reated with CyA and patients treated with FK (peak
xygen uptake in the CyA group was 15.5 ml/min/kg vs
5.9 ml/min/kg in the FK group; lactate threshold was
1% in the CyA group vs 29% in the FK group; Table 4).
o significant correlations (Spearman) were found be-
ween doses of corticosteroid and peak VO2 (r  0.30,
 0.15) and between doses of corticosteroid and
actate threshold (r  0.12, p  0.58). A weak, but
ignificant correlation (Spearman) was found between
ime on the waiting list and muscle force of the
uadriceps (r  –0.44, p  0.03). This correlation
uggests that lung transplant recipients with a long
aiting time have less muscle force of the quadriceps 1





(n  25) p-value
EV1 (liters) 0.94 (0.52) 2.65 (0.96) 0.001
% predicted 28.5 (12.8) 83.4 (27.3) 0.001
VC (liters) 2.15 (0.69) 3.30 (0.89) 0.001
% predicted 52.2 (16.9) 85.6 (22.6) 0.001
EV1/FVC (%) 46.5 (23.4) 79.9 (16.1) 0.001
LC (liters) 4.55 (1.88) 4.67 (1.01) 0.71
% predicted 80.3 (31.7) 81.7 (16.2) 0.81
aO2 at rest (kPa) 8.2 (1.3) 12.1 (1.2) 0.001
aCO2 at rest (kPa) 5.7 (1.3) 5.0 (0.5) 0.004
alues expressed as mean (SD); FEV1, forced expiratory volume in 1 second;
VC, forced vital capacity; TLC, total lung capacity; PaO2, arterial oxygen tension;
aCO2, arterial carbon dioxide tension.ear after transplantation.eripheral Muscle Force and Its Contribution to Limitation
f Exercise 1 Year After LTx
pper-extremity muscle force improved significantly
biceps: 168  53 N to 192  58 N, p  0.01; triceps:
17  36 N to 130  33 N, p  0.02). One year after
Tx, muscle force of the biceps was 101  17% of
redicted values and muscle force of the triceps was
5 28% of predicted values. Muscle force of the lower
imbs (quadriceps) improved significantly from 248 
3 N to 281  68 N and reached a value of 67  19 N
f predicted (Table 5). The predicted values of muscle
orce (corrected for weight) did not show significant
mprovement.
After LTx, muscle force of the quadriceps correlated
ignificantly with the peak load (r  0.41, p  0.05).
here was also a significant correlation between the
actate threshold and peak load (r  0.76, p  0.001)
nd peak VO2 (r  0.68, p  0.001). After LTx,
uadriceps muscle force correlated significantly with
actate threshold (r  0.53,  p  0.01) (Figure 1). The
orrelation between biceps muscle force and the LT
ust failed to reach significance (r 0.37, p 0.07) and




eak load (W) 11.6 (18.0) 68.6 (27.3)b
% predicted 7.4 (10.8) 50.8 (17.5)b
ardial
Peak heart rate 117 (19) 135 (17)b
Heart rate reserve (beats/min) 60 (19) 40 (18)b
entilatory
Peak VE exercise (liters/min) 21.0 (10.6) 42.4 (14.1)b
% predicted 62.7 (19.3) 46.1 (17.8)a
Breathing reserve (liters/min) 14.3 (12.7) 56.8 (31.8)b
VD/VT at max (%) 51.8 (8.7) 26.8 (8.5)b
PaCO2 at max (kPa) 5.8 (1.3) 4.8 (0.9)
b
xygen uptake
Peak VO2 (ml/min/kg) 8.6 (3.6) 15.7 (4.3)
b
% predicted 28.3 (9.4) 56.8 (14.8)b
PaO2 at max (kPa) 7.4 (1.1) 11.7 (2.1)
b
Increase in AaO2 (kPa) 1.02 (1.41)
c 1.70 (1.27)a,c
SaO2 at max (%) 88 (5) 96 (2)
b
eripheral muscle
Lactate at max (mmol/liter) 2.5 (2.2) 7.3 (2.6)b
LT (ml/min VO2) 477 (251)
d 541 (174)d
— 576 (241)e
LT (% predicted VO2) 22.4 (9.7)
d 28.1 (11.3)d
— 30.0 (11.3)e
alues expressed as mean (SD); PaCO2, arterial carbon dioxide tension; AaO2,
lveolar–arterial oxygen tension difference; VD/VT, dead-space ventilation; LT,
actate threshold.
ap  0.05 vs baseline.
bp  0.01 vs baseline.
cValues of 24 subjects.
dValues of 10 subjects.
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November 2006riceps muscle force did not significantly correlate with
T (r  0.30, p  0.15).
ISCUSSION
his study has demonstrated that maximal exercise
apacity (Wpeak and VO2max) improved significantly 1
ear after LTx. However, maximal exercise capacity did
ot reach normal values, despite (near) normal lung
unction in most recipients. After LTx, maximal exer-
ise capacity was reduced due to peripheral muscle
imitation in all recipients, which was reflected by
athologically low lactate thresholds. Peak muscle
orce of the quadriceps improved modestly after LTx,
ut remained low compared with age-, gender- and
eight-adjusted reference values. This is the first study
emonstrating, at well defined time-points, that periph-
ral peak muscle force plays an important role in the
imited exercise capacity after LTx, in line with the
ypothesis.
This study demonstrated clearly that exercise capac-
ty is significantly limited 1 year after LTx, which is
ompletely in line with previous findings.2–4,19,20 De-
pite the fact that the LTx recipients were studied in a
table clinical condition, they achieved peak VO2 at
pproximately 57% of predicted.
In contrast to pre-transplant exercise results there
as no evidence of a ventilatory limitation during
aximal exercise testing 1 year after LTx. Most patients
id not reach the predicted maximal heart frequency.
n DLT recipients, cardiac denervation may have been
esponsible for the lower peak heart rate. However, all
LT recipients underwent operation using bilateral
sequential single) LTx, which makes primary distur-
ance in cardiac function rather unlikely. All transplant
ecipients showed signs of lactic acidosis at an abnor-
Table 4. Differences in Exercise Performance and
Cyclosporine (CyA) and Patients Treated With Tacro
CyA
(N  12)
Peak VO2 (ml/min/kg) 15.5 (3.6)
LT (% predicted VO2) 31.3 (10.0)
Values expressed as mean (SD); peak VO2, peak oxygen u
able 5. Muscle Force Before and 1 Year After LTx
Baseline
(n  25)
At 1 year after
LTx (n  25) p-value
uadriceps muscles (N ) 248 (73) 281 (68) 0.02
% predicted 62.0 (18.6) 66.7 (18.6) 0.23
riceps muscles (N ) 117 (36) 130 (33) 0.02
% predicted 90.0 (28.1) 95.8 (21.2) 0.17
iceps muscles (N ) 168 (53) 192 (58) 0.01
% predicted 94.3 (28.0) 101.1 (17.0) 0.15talues expressed as mean (SD); N, newtons.ally low workload. All 25 LTx recipients had a patho-
ogic lactate threshold of 40% of the predicted value.
chwaiblmair and colleagues3 also demonstrated a re-
uced LT within 3 months after transplantation. Ac-
ordingly, Gibbons et al21 investigated 12 SLT recipi-
nts within 7 months after transplantation and observed
low LT. In the absence of a ventilatory, oxygen uptake
r cardiac limitation, these data indicate that peripheral
uscle dysfunction is a major cause of decreased
xercise capacity after LTx. However, 8 patients also
howed an increase in alveolar–arterial oxygen tension
f 2 kPa at maximal exercise, indicating a peripheral
imitation in combination with an oxygen uptake limi-
ation.
One component of peripheral muscle dysfunction is
he decreased aerobic capacity, as reflected by a low LT.
ecreased aerobic capacity may be due to muscle
epletion (especially loss of slow-twitch fibers), and to
mpaired aerobic enzyme deficits. Interestingly, cyclo-
porine has been shown to inhibit skeletal muscle
itochondrial respiration in vitro and to diminish en-
urance exercise time in rats. The mechanisms involved
re not clear, but seem to be related to diminished
itochondrial calcium efflux with subsequent mito-
igure 1. Scatterplot of the lactate threshold vs peripheral muscle
orce of quadriceps (r  0.53, p  0.01) 1 year after lung






15.9 (5.0) 0.39 0.825
28.9 (12.6) 2.47 0.594
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Volume 25, Number 11hondrial dysfunction.22,23 One year after transplanta-
ion there were no differences in aerobic capacity
etween patients treated with CyA and those treated
ith FK. Cyclosporine may also cause chronic anemia
n transplant recipients, resulting in reduced oxygen-
arrying capacity of the blood. However, all transplant
ecipients have maintained normal or mildly reduced
emoglobin values. Additional effects of medication,
uch as doses of corticosteroid, were also not related to
erobic capacity and lactate threshold.
Another component of peripheral muscle dysfunc-
ion is decreased peak muscle force. Our data show that
he mean peak muscle force of the quadriceps was
ecreased in LTx recipients compared with reference
alues. This may have been due to immobilization,
ub-optimal nutrition, catabolic conditions, critical ill-
ess neuropathy and pharmacologic treatment.24 In-
eed, potentially toxic medications are administered to
ll transplant recipients. For example, systemic ste-
oids, frequently prescribed pre- and post-LTx, may
nduce atrophy and myopathy in all peripheral mus-
les.7 Our data also show a significant, but weak
orrelation between time on the waiting list and muscle
orce of the quadriceps 1 year after transplantation. This
orrelation suggests that lung transplant recipients with
long waiting period have less muscle force 1 year after
ransplantation. However, time on the waiting list does
ot provide information about disease duration before
ssessment. Based on these data we could not deter-
ine the influence of disease duration on muscle force.
The results of this study suggest that both the muscle
erobic capacity and muscle peak force may contribute
o the limited exercise capacity observed after LTx.
owever, the direction of a possible causal relationship
etween muscle force and exercise capacity is unclear,
s limited exercise capacity may lead to decreased
hysical activities and muscle deconditioning and vice
ersa. An explanation for the positive correlation be-
ween peak quadriceps muscle force and the anaerobic
hreshold may be that patients with less muscle volume
evelop greater muscle tone at sub-maximal workloads,
esulting in impaired peripheral blood flow and early
actate production. To help determine the role of
re-transplant deconditioning vs possible effects of
mmunosuppressive medications, further comparable
tudies of, for example, other organ transplant groups,
ould be informative.
Previous studies detected LT by gas exchange,15
hich is an indirect and non-invasive method. In con-
rast, in the present study LT was assessed by measuring
he lactate concentration directly, and by plotting the
og blood lactate against the log VO2 and taking the
reak-point of the slope.17 This method detects the LT
ore reliably, because atypical records due to irregularreathing or a poor ventilatory response to metabolic pcidosis can be obviated. Despite this advantage, it
as not possible to detect LT in 15 subjects pre-LTx.
ue to early termination of the test, it was not
ossible to reach LT.
To our knowledge, only a few studies25,26 have
xamined the effects of a rehabilitation program on
ecipients of lung transplants. One study25 of 11 heart–
ung transplant recipients used an in-hospital exercise
raining program lasting 20 to 70 days and consisting of
upervised incremental treadmill walking, inspiratory
uscle training, abdominal muscle training and upper-
nd lower-extremity weight training. Skeletal (flexor
nd extensor leg muscles) and respiratory muscle func-
ion and exercise capacity improved with time, but
ere still below normal values after 18 months. In
nother study,26 a 6-week aerobic exercise training
rogram improved peak work and oxygen consump-
ion in lung transplant recipients; however, these im-
roved values were still only 55% to 65% of those of
ontrol subjects, and all transplant recipients stopped
xercising due to leg pain. No change was observed in
actate production and LT, which may indicate that
mprovements in skeletal muscle oxidative capacity did
ot occur.
Our study may have practical implications for pre-
nd post-LTx rehabilitation, although our results must
e interpreted with care due to the small number of
atients. Unfortunately, we did not have accurate data
n the exact exercise programs followed by the lung
ransplant recipients. However, the association be-
ween muscle force and lactate threshold in the present
tudy may underline the importance of early progres-
ive resistance training or high-intensity interval anaer-
bic training. The usefulness of resistance training, as a
upplement to conventional aerobic exercise, has been
learly shown in patients with COPD and CF.27–30 It is
ifficult to determine whether the training stimulus
sed in previous studies was adequate for providing an
mprovement in exercise capacity and LT. Therefore,
he optimal training strategies for lung transplant recip-
ents remain to be determined in further research.
A potential limitation of this study is the heteroge-
eous study population, consisting of six different
iseases. On the other hand, there is a universal prob-
em of limited exercise capacity after LTx due to muscle
erformance. Apparently, the post-LTx factors respon-
ible for this muscular deficit are present, irrespective
f the underlying disease.
In conclusion, exercise capacity is reduced in lung
ransplant recipients. Despite (near) normal lung func-
ion, all patients demonstrated an early and pathologic
actate threshold, even 1 year after transplantation. The
resence of early, pathologic lactate threshold and
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November 2006ion of exercise capacity and reflects a peripheral deficit
ost-LTx.
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